BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26148698)

  • 1. [Personalized tumor therapy for gastrointestinal tumors].
    Ettrich TJ; Perkhofer L; Seufferlein T
    Internist (Berl); 2015 Sep; 56(9):1069-78. PubMed ID: 26148698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gastrointestinal stromal tumors (GIST)].
    Reichardt P; Reichardt A
    Dtsch Med Wochenschr; 2013 Oct; 138(40):2013-6. PubMed ID: 24065407
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular targets in GI malignancies - A pathologist's perspective.
    Pawar S; Sharma A
    Indian J Pathol Microbiol; 2021 Jun; 64(Supplement):S43-S51. PubMed ID: 34135137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precision Medicine in Gastrointestinal Pathology.
    Wang DH; Park JY
    Arch Pathol Lab Med; 2016 May; 140(5):449-60. PubMed ID: 27128302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Profiling in Gastrointestinal Cancer: Are We Ready To Use These Data to Make Treatment Decisions?
    Goldberg RM
    Oncologist; 2015 Dec; 20(12):1448-56. PubMed ID: 26512044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Personalized therapy for gliomas].
    Wick W; Hau P
    Nervenarzt; 2015 Jun; 86(6):692, 694-6, 698-700. PubMed ID: 26022855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapies and predictive markers in epithelial malignancies of the gastrointestinal tract.
    McIntire M; Redston M
    Arch Pathol Lab Med; 2012 May; 136(5):496-503. PubMed ID: 22229849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCRUM-Japan GI-SCREEN and MONSTAR-SCREEN: Path to the realization of biomarker-guided precision oncology in advanced solid tumors.
    Nakamura Y; Fujisawa T; Taniguchi H; Bando H; Okamoto W; Tsuchihara K; Yoshino T; Ohtsu A
    Cancer Sci; 2021 Nov; 112(11):4425-4432. PubMed ID: 34510657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing pathology with changing drugs: tumors of the gastrointestinal tract.
    Cervera P; Fléjou JF
    Pathobiology; 2011; 78(2):76-89. PubMed ID: 21677471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Personalized therapy concepts for malignant melanoma].
    Schlaak M; Kreuzberg N; Mauch C; Kurschat P
    Internist (Berl); 2013 Feb; 54(2):188-93. PubMed ID: 23371260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
    Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
    Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Approaches to Gastrointestinal Cancers: Importance of Integrating Genomic Information to Guide Therapy.
    He J; Ahuja N
    Surg Clin North Am; 2015 Oct; 95(5):1081-94. PubMed ID: 26315525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
    Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
    Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key Lessons Learned from Moffitt's Molecular Tumor Board: The Clinical Genomics Action Committee Experience.
    Knepper TC; Bell GC; Hicks JK; Padron E; Teer JK; Vo TT; Gillis NK; Mason NT; McLeod HL; Walko CM
    Oncologist; 2017 Feb; 22(2):144-151. PubMed ID: 28179575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiles in foregut oncology.
    Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
    Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lung cancer. Molecular pathology and personalized therapy].
    Schultheis A; Wolf J; Büttner R
    Internist (Berl); 2013 Feb; 54(2):179-80, 182-7. PubMed ID: 23371257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Breast cancer. Individualized therapy concepts].
    Harbeck N; Wuerstlein R
    Internist (Berl); 2013 Feb; 54(2):194-9. PubMed ID: 23371261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers for personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2015 Mar; 64(3 Suppl 1):S16-21. PubMed ID: 25468140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.